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Chorea-acanthocytosis (ChAc) is a fatal neurological disorder characterized by red blood cell acanthocytes and striatal neurodegeneration.
Recently, severe cell membrane disturbances based on depolymerized cortical actin and an elevated Lyn kinase activity in erythrocytes from
ChAc patients were identified. How this contributes to the mechanism of neurodegeneration is still unknown. To gain insight into the patho-
physiology,weestablishedaChAcpatient-derivedinducedpluripotentstemcellmodelandanefficientdifferentiationprotocolprovidingalarge
population of human striatalmedium spiny neurons (MSNs), themain target of neurodegeneration in ChAc. Patient-derivedMSNs displayed
enhancedneurite outgrowthandramification,whereas synapticdensitywas similar to controls. Electrophysiological analysis revealedapatho-
logicallyelevatedsynapticactivity inChAcMSNs.Treatmentwith theF-actinstabilizerphallacidinor theSrckinase inhibitorPP2resulted in the
significant reduction of disinhibited synaptic currents to healthy control levels, suggesting a Src kinase- and actin-dependentmechanism. This
was underlined by increasedG/F-actin ratios and elevated Lyn kinase activity in patient-derivedMSNs. These data indicate that F-actin stabili-
zation and Src kinase inhibition represent potential therapeutic targets in ChAc thatmay restore neuronal function.
Keywords: actin cytoskeleton; chorea-acanthocytosis; human inducedpluripotent stemcells; patch-clampelectrophysiology; Src kinase;
striatal medium spiny neurons
Introduction
Neuroacanthocytosis (NA) syndromes are characterized by pro-
gressive degeneration of the basal ganglia and abnormal spiny red
blood cells called acanthocytes. The core NA syndromes are the
autosomal-recessive chorea-acanthocytosis (ChAc) and the
X-linked McLeod syndrome, with an estimated prevalence of
1–5 per 1,000,000 inhabitants of the general world population
(Danek et al., 2001; Al-Asmi et al., 2005; Dobson-Stone et al.,
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Significance Statement
Chorea-acanthocytosis (ChAc) is a fatal neurodegenerative diseasewithout a known cure. To gain pathophysiological insight, we newly
established a human in vitromodel using skin biopsies from ChAc patients to generate disease-specific induced pluripotent stem cells
(iPSCs) and developed an efficient iPSC differentiation protocol providing striatal medium spiny neurons. Using patch-clamp electro-
physiology,wedetected apathologically enhanced synaptic activity inChAcneurons.Healthy control levels of synaptic activity couldbe
restored by treatment of ChAc neurons with the F-actin stabilizer phallacidin and the Src kinase inhibitor PP2. Because Src kinases are
involved in bridging the membrane to the actin cytoskeleton by membrane protein phosphorylation, our data suggest an actin-
dependentmechanismof this dysfunctional phenotype and potential treatment targets in ChAc.
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2005; Jung et al., 2011; Hermann and Walker, 2015). ChAc is
described as a progressive hyperkinetic movement disorder with
cognitive dysfunction, behavioral abnormalities, and variable ac-
anthocytosis of red blood cells. In the progression of the disease,
most patients develop a characteristic phenotype including cho-
rea, a “feeding dystonia” with tongue protrusions (Bader et al.,
2010), orofacial dyskinesia, involuntary vocalizations, dysarthria,
and involuntary tongue and lip biting. ChAc is associated with
epileptic seizures often appearing as initial symptoms in adoles-
cence and additional multisystem features including myopathy
and axonal neuropathy of variable degree. Cerebralmagnetic res-
onance imaging may demonstrate striatal atrophy. The disease
course usually begins in the second to the third decade and pro-
gresses chronically tomajor disability and premature death of the
patient due to various complications after 15–30 years (Jung et
al., 2011). There is currently only symptomatic treatment
available.
ChAc is caused by mutations in the VPS13A gene leading to a
loss of the protein chorein that is expressed in various cell types
(Ueno et al., 2001; Velayos-Baeza et al., 2004). Chorein is a very
large protein suggested to be involved in vacuolar protein sorting
and morphogenetic membrane regulation in yeast (Ueno et al.,
2001; Velayos-Baeza et al., 2004; Park and Neiman, 2012). The
insufficient pathophysiological knowledge regarding ChAc re-
lates to the lack of specific chorein antibodies and the limited
availability of suitable (especially mammalian) animal models
(Tomemori et al., 2005). Western blots for chorein demonstrate
absence of this protein in red blood cells of ChAc patients
(Dobson-Stone et al., 2002, 2004, 2005). Despite the identifica-
tion of causative mutations in theVPS13A gene several years ago,
the detailed function of the encoded protein and themechanisms
bywhich the disease-specificmutations cause neurodegeneration
remain unclear. The association of the acanthocytic membrane
abnormality with neurodegeneration, however, suggests a com-
mon pathogenetic pathway.
Recently, severe actin-related cell membrane disturbances
and elevated Lyn kinase activity in erythrocytes from ChAc pa-
tients have been identified (De Franceschi et al., 2011a; Fo¨ller et
al., 2012; Schmidt et al., 2013; Honisch et al., 2015). Actin nega-
tively regulates vesicle fusion, as demonstrated by experiments in
which depolymerization of cortical actin stimulates exocytosis in
a variety of non-neuronal cell types (Burgoyne and Cheek, 1987;
Muallem et al., 1995; Vitale et al., 1995). The polymerized formof
actin, filamentous or F-actin, is the major cytoskeletal element
identified in presynaptic nerve terminals (Fifkova´ and Delay,
1982; Gotow et al., 1991). In cultured hippocampal neurons,
F-actin depolymerization by latrunculin A increases exocytosis
rapidly by amechanism independent of intracellular Ca2. These
findings indicate that either actin itself or proteins that link to the
actin cytoskeleton participate in a regulatory mechanism that
restrains fusion of synaptic vesicles at the active zone (Morales et
al., 2000).
To investigate pathophysiological mechanisms, we estab-
lished a human in vitromodel of ChAc using reprogrammed skin
fibroblasts from patients to generate disease-specific induced
pluripotent stem cells (iPSCs). We hypothesized that a disturbed
actin polymerization in ChAc leads to a pathological synaptic
hyperactivity preceding degeneration of striatal GABAergic in-
terneurons. Therefore, we developed an efficient iPSC differenti-
ation protocol providing a large number of striatalmedium spiny
neurons (MSNs) and performed detailed functional analyses of
voltage- and ligand-gated ion channels and synaptic activity of
disease-specific neurons and healthy controls to identify poten-
tial therapeutic targets for the treatment of ChAc.
Materials andMethods
Induction, cultivation, and three-germ-layer differentiation of human
iPSCs (hiPSCs). Skin biopsy of lines not published previously was taken
after informed consent according to the approval of the ethical commit-
tee of the Medical Faculty of the Technische Universita¨t Dresden (EK
45022009). Human dermal fibroblasts (HDFs) of two female ChAc pa-
tients (born 1977 and 1962), referred to asmutant (Mut), as well asHDFs
from healthy sex- and age-matched control persons (born 1965 and
1959) referred to as wild-type (WT), were reprogrammed to iPSCs as
described previously (Reinhardt et al., 2013a). Briefly, HDFs were retro-
virally transduced with OCT4, SOX2, KLF4, and c-MYC. After 14–21 d,
emerging iPSC colonies were isolated clonally and further cultivated.
hiPSCs were cultivated on mitomycin C (Tocris Bioscience)-
inactivated mouse embryo fibroblast feeder cells in human embryonic
stem cell (hESC) medium, which consisted of knock-out DMEM (Life
Technologies), 20% knock-out serum replacement (Life Technologies),
0.1 mM -mercaptoethanol, 1% penicillin/streptomycin/glutamine
(PSG), 1% nonessential amino acids, and 5 ng/ml human FGF2 (Pepro-
tech). iPSCs were passaged every 5–7 d using 1 mg/ml collagenase IV or
dispase (both from Life Technologies).
For three-germ-layer differentiation, iPSCs were detached from the
feeder layer as colonies to form embryoid bodies (EBs) using 2 mg/ml
collagenase IV for 45min. Colony pieces were collected by sedimentation
and resuspended in hESC medium without FGF2 supplemented with 1
M dorsomorphin (Tocris Bioscience), 10 M SB-431542 (Abcam), and
5 M Y27632 Rho-kinase (ROCK) inhibitor, and plated onto non-cell-
culture-treated plastic Petri dishes to form EBs. Two and 4 d later, the
medium was changed to hESC medium without any additional supple-
ments. Six days later, EBs were either plated on Matrigel (BD
Biosciences)-coated plastic dishes in N2B27 medium (see below) for
ectoderm formation or on gelatin (Sigma-Aldrich)-coated plates in
DMEM with 1% PSG and 20% fetal calf serum (Biochrom) for meso-
derm and endoderm differentiation. Themediumwas changed every 3 d
and cells were fixed and analyzed by immunocytochemistry after 2weeks.
Differentiation of striatal MSNs. To differentiate hiPSCs into MSNs,
colonies were detached from the feeder layer using collagenase or dispase
2–3 d after splitting to form EBs. Detached colonies were collected by
sedimentation and resuspended in hESCmediumwithout FGF2, supple-
mented with 1 M dorsomorphin, 10 M SB-431542, 1 M IWP2
(Millipore), and 5 M Y27632 ROCK inhibitor, and plated on non-cell-
culture-treated plastic Petri dishes to prevent cell attachment (day 0).
Two days later, themediumwas replaced with a 1:1mixture of hESC and
N2 medium (DMEM/F-12, with 1:100 N2 supplement, both Life Tech-
nologies, 1% PSG), supplemented with the same concentrations of dor-
somorphin, SB-431542, and IWP2 asmentioned above (day 2). Twodays
later, the medium was changed to N2 medium with the same combina-
tion of small molecules (day 4). On days 6 and 8, the medium was re-
placed with N2 medium containing 0.6 M purmorphamine (PMA;
Alexis) and 1 M IWP2. On day 10, small-molecule supplements were
withdrawn and, on days 12–14, EBs were plated on Matrigel-coated
plates (Corning) in N2B27 maturation medium (1:1 DMEM/F-12 and
Neurobasal medium containing 1:200 N2, 1:100 B27 without vitamin A,
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all from Life Technologies, and 1% PSG), supplemented with 20 ng/ml
brain-derived neurothropic factor (BDNF), 10 ng/ml glial cell line-
derived neurotrophic factor (GDNF), 1 ng/ml transforming growth
factor- 3 (TGF3) (all from Peprotech), and 0.5 mM dibutyryl-cAMP
(dbcAMP; Sigma-Aldrich). The medium was changed every other day.
Once the outgrowing cells became too confluent (days 20–24), cells were
replated. Cultureswere treated for 2minwith fresh, prewarmedAccutase
(Sigma-Aldrich), washed once with PBS and N2B27 each, and detached
in maturation medium with a cell scraper. After pipetting to break the
cell clusters into smaller clumps, cells were replated at a 1:3 ratio on fresh
Matrigel-coated plates in maturation medium. To replate the cultures as
single cells at day 30 or at earlier time points, as indicated, neuronal
cultures were digested using fresh, warm Accutase supplemented with
10 M Y27632 ROCK inhibitor for up to 1 h. Cultures were carefully
pipetted to a single-cell suspension, diluted at least 1:10 in N2B27 me-
dium with ROCK inhibitor, collected by centrifugation for 5 min at
200  g, and replated in maturation medium with ROCK inhibitor.
ROCK inhibitor was withdrawn the day after splitting.
Cell quantification after long-term cell culture. Mature MSNs were dif-
ferentiated for at least 3 months (4 separate experiments using 5 healthy
control and 4 ChAc clones). Cells were washed once with PBS and then
treatedwith Accutase for 1 h. The reaction solutionwas then dilutedwith
DMEM/F12, centrifuged at 200 g for 4min, the supernatant discarded,
and the pellet resuspended in a 1:1 mixture of DMEM/F12 and Neuro-
basal medium without phenol red. Cells were gently triturated to yield a
homogeneous suspension. The solution was incubated with 7.5 g/ml
Hoechst33342 (Life Technologies) and analyzed with excitation at 360
nm and measuring emission at 460 nm using a GENios fluorescence
microplate reader (Tecan) and Magellan version 7.2 software (Tecan).
Background valueswere obtained bymeasuring 7.5g/mlHoechst33342
in cell-free solution and deducted from the samples. Quantification was
done relative to healthy controls and a Student’s t test with p  0.05
considered significant.
Differentiation of midbrain dopaminergic neurons. iPSCs were con-
verted into neural precursor cells that could be maintained indepen-
dently and propagated to yield a homogeneous starting condition for
differentiation into tyrosine hydroxylase-positive midbrain dopaminer-
gic neurons (mDANs), as described previously (Reinhardt et al., 2013b).
In short, 1  105 cells per cm2 were seeded in PLO/laminin-coated
dishes and fed with N2B27 medium (1:1 DMEM/F-12 and Neurobasal
medium containing 1:200N2, 1:100 B27 without vitamin A, all from Life
Technologies, and 1% PSG), supplemented with 200MAA, 1M PMA,
and 100 ng/ml FGF8 (R&D Systems) every other day for 10 d. Thereafter
cells were splitted using Accutase (Life Technologies) and reseeded with
a density of 5 104 cells per cm2 on PLO/laminin-coated dishes and fed
every other day for 14 dwithN2B27medium supplemented with 200M
AA (Sigma-Aldrich), 5 ng/ml BDNF (Promega), 10 ng/ml GDNF
(Sigma-Aldrich), 1 ng/ml TGF-3 (Peprotech), and 250 M dbcAMP
(Sigma-Aldrich). Differentiated mDANs were only used for Western
blots of the G/F-actin ratio and Lyn kinase activation levels compared
with MSNs.
G/F-actinWestern blots. The protocol for G/F-actinWestern blots was
adapted from Fo¨ller et al. (2012). Mature neurons were washed with
ice-cold PBS containing phosphatase inhibitor (Thermo Fisher Scien-
tific). Cells were then incubatedwith extraction buffer consisting of 0.3%
Triton X-100 (Thermo Fisher Scientific), 5 mM Tris/HCl (Roth), pH 7.4,
2 mM EGTA (Roth), 300 mM sucrose (Roth), 2 M phalloidin (Tocris
Bioscience), and 1:100 protease inhibitor (ThermoFisher Scientific) for 5
min on ice. The supernatant was collected and the same volume of RIPA
lysis buffer was applied containing 50 mM Tris/HCl, pH 7.4, 1% Triton
X-100, 1% sodium deoxycholate (Sigma-Aldrich), 0.1% SDS (Roth),
0.15 M NaCl (Roth), 1 mM EDTA (Roth), 1 mM DTT (Roth), and 1 mM
sodium orthovanadate (Sigma-Aldrich). Cells were scrapped off and in-
cubated in the lysis buffer for 15 min on ice. The remaining insoluble
pellet was removed by centrifugation at 10,000  g for 2 min and dis-
carded. Globular actin (G-actin) and filamentous actin (F-actin)-
containing fractions were both mixed 3:1 with SDS loading buffer (Life
Technologies) and 10l was pipetted into precast 12%Bis-Tris gels (Life
Technologies). For 75 min, 140 V/60 mA were applied to the gels, which
were then blotted on nitrocellulosemembranes (Life Technologies) for 8
min using the dry blot system iBlot (Life Technologies). Membranes
were blocked for 1 h using 5% skim milk powder solved in PBST. Rabid
polyclonal anti-actin (1:500; Cell Signaling Technology) was diluted in
1% skim milk PBST solution and incubated overnight. Samples were
washed 5 times with PBST and then incubated for 1 h with HRP-
conjugated secondary antibody (1:5000; Jackson ImmunoResearch) dis-
solved in 1% skim milk PBST solution. Membranes were washed four
times with PBST and one time with ddH2O before development was
conducted using the ECL Western blot detection kit (GE Healthcare)
with an LAS3000 imager (Fujifilm). Densitometry was done using Total-
Lab Quant software. For quantification of G/F-actin ratios by Western
blots, we compared MSNs (5 separate experiments using a total of 17
healthy control and 9 ChAc clones) and mDAN (3 independent experi-
ments with 16 control and 9 ChAc clones) using a Student’s t test with
p 0.05 considered significant.
Lyn kinase Western blot. MSNs and mDAN (3 independent experi-
ments with up to 3 ChAc and control clones) were lysed in Bicina-based
buffer in presence of proteasome 20S inhibitor, bortezomib) as described
previously (De Franceschi et al., 1997, 2011b; Franco et al., 2014). For
mono-dimensional electrophoresis, proteins from neurons were solubi-
lized in reducing sample buffer (50 mM Tris, pH 6.8, 2% w/v SDS, 10%
v/v glycerol, 100 mM -mercaptoethanol, and a few grains of bromphe-
nol blue). Gels were transferred to nitrocellulose membranes for immu-
noblot analysis with specific antibodies anti-Lyn (2732; Cell Signaling
Technology), anti-phospho-Lyn (p-Lyn 396; Cell Signaling Technol-
ogy), and anti-GAPDH or anti-actin (Sigma-Aldrich). Blots were devel-
oped using HRP chemiluminescence detection reagents. Densitometric
analysis of band intensities was performed with Quantity One analysis
software (Bio-Rad) using a Student’s t test with p  0.05 considered
significant.
Cofilin and profilin Western blots. For Western blot analysis of cofilin
and profilin 2a, frozen iPSC pellets were lysed with RIPA buffer contain-
ing the following (in mM): 137 NaCl, 50 NaF, 20 Tris-HCl, pH 7.5, 25
b-glycerophosphate, 2 EDTA, 1 sodium orthovanadate, and 1 phenylm-
ethylsulfonylfluoride (PMSF) plus 2% (v/v) protease inhibitor cocktail
(EDTA-free; Roche), 1% (v/v) Triton X-100, 1% (w/v) sodium desoxy-
cholate, and 1% (v/v) phosphatase inhibitor cocktail 1 (Roche), soni-
cated, and incubated for 30 min on ice. Nonsoluble debris were
centrifuged and protein concentration on the supernatant was deter-
mined with a BCA assay (Pierce). SDS-PAGE and Western blots were
performed with equal protein amounts as described previously (Claus
et al., 2003). Blots for incubation with anti-phospho-antibodies were
blocked with BSA, all other blots were blocked with dried milk in
TBS–Triton.
The following primary antibodies were used forWestern blot analysis:
mouse anti-III tubulin (1:3000, clone 2G10, 05–559;Millipore), mouse
anti-GAPDH(1:4000;Millipore), rabbit anti-phospho (Ser-138) profilin
(1:1000, PPU4791; ECM Biosciences), rabbit anti-profilin (1:1000,
PPU821; ECM Biosciences), rabbit anti-phospho (hSer-3) cofilin (1:
1000, sc-12912R; Santa Cruz Biotechnology), rabbit anti-cofilin (D3FD)
XP (1:1000; CST; 5175). HRP-conjugated secondary antibodies (sheep
anti-mouse, 1:4000, GE Healthcare; goat anti-rabbit, 1:4000, Pierce)
were used for visualization by chemiluminescence imaging using Immo-
bilon reagent (Millipore).
Immunocytochemical staining. Cells were fixed with 4% paraformalde-
hyde and blocked for 45min in blocking buffer (5%goat serum, 1%BSA,
0.3% Triton X-100 in PBS). Primary antibodies were as follows: mouse
monoclonal anti- III tubulin (TUBB3, 1:500, Millipore or 1:1000, Co-
vance), rabbit polyclonal anti-Map2 (1:500, Cell Signaling Technology,
or 1:1000, Santa Cruz Biotechnology), rabbit polyclonal anti-GABA (1:
2000; Sigma-Aldrich), mouse monoclonal anti-GABA (1:200; Sigma-
Aldrich), rabbit polyclonal anti-DARPP32 (1:200; Santa Cruz
Biotechnology), mouse monoclonal anti-Nestin (1:300; R&D Systems),
rabbit polyclonal anti-FOXG1 (1:300; Abcam), mouse monoclonal anti-
GAD67 (1:200;Millipore), goat polyclonal anti-SOX2 (1:200; Santa Cruz
Biotechnology), mouse monoclonal anti-OCT4 (1:100; Santa Cruz Bio-
technology), goat polyclonal anti-NANOG (1:50; R&D Systems), mouse
monoclonal anti-TRA1–81 (1:100; Millipore), mouse monoclonal anti-
Stanslowsky, Reinhardt et al. • Neuronal Dysfunction in iPSC-Derived MSNs J. Neurosci., November 23, 2016 • 36(47):12027–12043 • 12029
SSEA4 (1 g/ml; Developmental Studies Hybridoma Bank), mouse
monoclonal anti-AFP (1:300; Sigma-Aldrich), and mouse monoclonal
anti-SMA (1:100, Dako) were applied overnight at 4°C. Appropriate sec-
ondary antibodies (Alexa Fluor labeled, 1:500, Life Technologies) were
incubated for 1 h at room temperature and nuclei were counterstained
with DAPI (10 mg/ml; Life Technologies) or Hoechst (Applichem), as
indicated. Images were taken with an Olympus DP72 camera under an
Olympus BX61 fluorescent microscope using the image-analysis soft-
ware Cell F (Olympus) or on a Zeiss Axiovert Fluorescence microscope.
Cell counts were performed within three randomly selected visual fields
from at least three independent differentiation experiments. Cell counts
for the differentiation efficiencies were performed with the Cellomics
ArrayScan in an automated fashion on cultures that were fixed 2 d after
reseeding.
Analysis of neuronal morphology and synaptic density. Cultures were
stained with a III-tubulin antibody (1:500; Millipore), as well as an
antibody directed against GABA (1:2000; Sigma-Aldrich) and images
were taken with an Olympus BX60 using Olympus cellSens imaging
software. The experimenter performing microscopy and analysis was
blinded and images were arbitrarily selected. All automated imaging ac-
quisition algorithms were inactivated and pictures were taken with a
constant exposure time and gain for each channel, ensuring comparabil-
ity between images. Images were preprocessed using a preinstalled Im-
ageJ version 1.46r algorithm unsharp mask with a radius () of 1.0 and a
mask weight of 0.6. ImageJ-based plugin NeurphologyJ (Ho et al., 2011)
was used to quantify soma, neurites, attachment points, and end points.
Briefly, the plugin uses two different thresholds for somata and neurites,
as well as the information of the approximate neurite thickness for de-
tection and quantification of number of somata and neurites, the area of
somata and neurites, and the total neurite length within an image. Those
parameters were used to normalize neurites by somata obtaining a quan-
titative expression for total neurite outgrowthwithin an image. Similarly,
the end points of a neurite were normalized by soma attachment points
receiving an expression for ramification. GABAergic staining was used
for quantification of synaptic density using the ImageJ plugin Synap-
CountJ (version 2.0) andNeuronJ (version 1.4.3) (Meijering et al., 2004)
as described previously (Hensel et al., 2016). Briefly, NeuronJwas used to
trace a neurite with a distance of 30 m to the soma for a total length of
at least 100 m. This tracing was applied to SynapCountJ, in which
GABA-positive spots along the tracing were detected within an intensity
threshold. 20 images of each culture were analyzed for morphology and
synaptic density and each of the different quantitative outcomes were
averaged to a single value avoiding pseudo-replicates. This value was
subsequently subjected to statistical analysis using a Student’s t test with
p 0.05 considered significant.
Electrophysiology. Electrophysiologicalmeasurements of twoChAcpa-
tient and three control cell lines were performed after 40 d of differenti-
ation in vitro from at least three independent differentiation experiments
as described previously (Stanslowsky et al., 2014). In brief, patch pipettes
with final resistances of 3–4 M were filled with the internal solution
consisting of the following (in mM): 153 KCl, 1 MgCl2, 10 HEPES, 5
EGTA, and 2 Mg-ATP, adjusted to pH 7.3 with KOH (305 mOsm). The
bath solution contained the following (inmM): 142NaCl, 8 KCl, 1 CaCl2,
6MgCl2, 10 glucose, and 10HEPES, adjusted to pH 7.4 with NaOH (325
mOsm). Whole-cell currents were low-pass filtered at 2.9 kHz, digitized
at 10 kHz using an EPC-10 amplifier (HEKA), and analyzed with Patch
Master (HEKA). Sodium and potassium ion currents were elicited by
depolarizing voltage steps in increments of 10mV from a holding poten-
tial of 70 to 40 mV. Miniature postsynaptic currents (mPSCs) were
acquired by recording 72 s traces at a holding potential of 70 mV.
Action potentials (APs) were evoked in response to depolarizing current
pulses in current-clamp mode. Spontaneous APs and membrane poten-
tials were recorded by clamping the cells at 0 pA. Tetrodotoxin (TTX,
1 M), tetraethyl ammonium chloride (TEA, 10 mM), bicuculline (10
M), and NBQX (10 M, all purchased from Sigma-Aldrich) diluted in
the bath solution were applied via gravity using a modified SF-77B per-
fusion fast-step system (Warner Instruments).
Drug treatment of differentiating hiPSCs. To investigate the influence of
the F-actin stabilizer phallacidin (Santa Cruz Biotechnology) and the
inhibitor of the Src-family of tyrosine kinases, PP2 (Sigma-Aldrich), on
electrophysiological properties of differentiating hiPSCs in vitro, separate
functional experiments were performed. After 37 d of differentiation,
cells from ChAc patients and healthy controls were treated with 100 nM
phallacidin or 10 M PP2 for 72 h before analysis. Appropriate controls
without drug treatments were cultured in parallel. The given drug
concentrations were chosen because they had no effects on cell via-
Table 1. List of oligosequences used for qRT-PCR analysis
Gene Primer sequence (5¡3)
Nav1.1 fw: TGTGGACATCGGCGCACCTG, rev: ACACAGCCTTCAGTGAAACAAGCTT
Nav1.2 fw: TGCTCCCCATCCTGCCCATGA, rev: TAGTTGTGCCCTCTGGTAGGAGCT
Nav1.3 fw: AGGCTCTTGGCAAGCAAGCTCG, rev: ATGTGGCCACTTGAAGCAGTGCA
Nav1.5 fw: TGGCGGTTGCGCAAGACCTG, rev: GTCCTCGAAGGCCAGCGCTC
Nav1.6 fw: CCATTGTGGGAATGTTCCTGGCAG, rev: ATGCGCCCAATACGGGCCAA
Nav1.7 fw: CCGGTCAAGCTCCTCAGAGTGC, rev: ACACAACCATCTGTGAAACAGGCC
Nav1.8 fw: AAGCATAGGGAGCAGAAGGACCAA, rev: AGGGGCTCCCCGATCAGTTCTG
Nav1.9 fw: AATCAGCTCCCAAGGCCCCTGAC, rev: AAGGCCTCAGGAGGCGGGAATAAA
Nax fw: TCTCCATCACAGGACTATGTCTGCC, rev: TGGTCCTTTTCCAAGACGCAGCA
Nav1 fw: GGAGTTTGTCAAGATCCTGCGCT, rev: GGTCTTTGGTGCCCCGGCTG
Nav2 fw: TCATGGAAGAGCCCCCTGAGCG, rev: GCACCAAGATGACCACAGCCAGG
Nav3 fw: GGCAGCCCAAGAAAACGCGTC, rev: GGTGTTCAGGCCACCTCATGTCA
Nav4 fw: CTGTCGTGGGCGGGGTCATC, rev: AGCTCACGAGACACTCCTTCTTCT
Cav1.2 fw: TCGGCAACTGACGCTCCCAGA, rev: GGCCCTTCGACCTAGTGAGGC
Cav1.3 fw: CGGACCCCGTCCTCGAAGGA, rev: CCTACGCGGATCGGGTTGGT
Cav2.1 fw: ACCGGCAGGGCAGTAGTTCCG, rev: CACAGGGGAATAGGACACGTGTGG
Cav2.2 fw: TGCTGTTCAGGAGCGCCACG, rev: CGGTGGCATTGGCCTGCTCA
Cav2.3 fw: GTGGCCCTGGGGTTCATCTTCCATA, rev: CAGGATGCCACTGAGGACCACGA
Cav3.1 fw: TCAGCCTCCCCCTGAGCGTG, rev: TTCTGCAGGACCGCATGCCG
Cav3.2 fw: GGTTCCGCGTCTCCTGCCAG, rev: AGGAAGACCCGCTCGGTGCT
Cav3.3 fw: AGGCGGAGGGTGACGCCAAT, rev: CCGCTGCTGTCCAGGCCTTC
Cav21 fw: TGGAACCAAATAATGCACGCCAGCT, rev: CCAGGCGCACCAGGGCTTTAG
Cav22 fw: TCACTCGGGCCAACTGCAACA, rev: TAAACACGCGCACCGTCCGG
Cav23 fw: ACCGAAAATGGTACATCCAGGCAGC, rev: TGCTTCGCGATAGTCAGACGGAGT
Cav1b fw: AGGTCTTCGACCCCAGCCCG, rev: GCTGAGCCCTGGCGGACAAA
Cav2a fw: CTGGCTCAGTGTCCTCCAGAGCT, rev: TGGGAGGATGGGTGGCCTTCC
Cav3 fw: TGAGGACTCGGAGGCGGGTTC, rev: GCTCTCTACTTCACGCCGGGC
Cav4 fw: GAGGACGTTTTCACGGAGGGAAA, rev: TGCTGTTGATGTGGGAGTTGCTCG
Cav2 fw: CGCACCCAAGCGAGCACTGT, rev: CCCAGAACCCAGGCCTTGCG
Cav3 fw: AGAGCGGAGGAACCGGGTCG, rev: CAAGCCCACTCTCCGCGCAA
Cav4 fw: TACCTCCTCCGCATCGTGCGA, rev: ATCCTGCCAGCACCGATGCAC
Cav5 fw: TTTTAACGGAGAGTGCCGGGGTG, rev: TGCTCAGCCGAGGGCGGTA
Cav6 fw: TCTGGATCGATTCACTTGCCGGG, rev: TCACAGCGAGGCCAGACCCTT
Cav7 fw: TCCTACTCAAAGAGGGGGCCGG, rev: AAGGCCGGGTGTGGACGGTA
Cav8 fw: ACTTCGGAGGGCTGTCGTTC, rev: CGAGACTGGCAGTGCGCCTC
B2M fw: TGCCTGCCGTGTGAACCATGT, rev: TGCGGCATCTTCAAACCTCCATGA
GAPDH fw: CTGGTAAAGTGGATATTGTTGCCAT, rev: TGGAATCATATTGGAACATGTAAACC
B-ACT fw: TCAAGATCATTGCTCCTCCTGAG, rev: ACATCGCTGGAAGGTGGACA
OCT4 endo fw: GGAAGGAATTGGGAACACAAAGG, rev: AACTTCACCTTCCCTCCAACCA
SOX2 endo fw: TGGCGAACCATCTCTGTGGT, rev: TGGCGAACCATCTCTGTGGT
KLF4 endo fw: ACAGTCTGTTATGCACTGTGGTTTCA, rev: CATTTGTTCTGCTTAAGGCATACTTGG
c-MYC endo fw: CCAGCAGCGACTCTGAGGA, rev: GAGCCTGCCTCTTTTCCACAG
DPPA4 fw: TGGTGTCAGGTGGTGTGTGG, rev: CCAGGCTTGACCAGCATGAA
LIN28 fw: GGAGGCCAAGAAAGGGAATATGA, rev: GGAGGCCAAGAAAGGGAATATGA
OCT4 viral fw: GGCTCTCCCATGCATTCAAAC, rev: GGCTCTCCCATGCATTCAAAC
SOX2 viral fw: GCACACTGCCCCTCTCACAC, rev: CACCAGACCAACTGGTAATGGTAGC
KLF4 viral fw: CCTCGCCTTACACATGAAGAGACA, rev: CACCAGACCAACTGGTAATGGTAGC
c-MYC viral fw: GCTACGGAACTCTTGTGCGTGA, rev: GCTACGGAACTCTTGTGCGTGA
MAP2 fw: GATGAGAATTCCTTCTCTCTCAAC, rev: AGGAGTGATGGCAGTAGACC
GAD67 fw: GCTACGGAACTCTTGTGCGTGA, rev: ATCCAGTGGAGAGCTGGTTG
FOXG1 fw: TAGGTAAACCTTGCAAATATGTAACC, rev: CGGGCATATGACCACAGTATC
Cofilin fw: CTCGTCTTCTGCGGCTCTCGG, rev: CTTGCGCTTCTTCACCTCCTCTGG
Profilin fw: GTGGAACGCCTACATCGACAACC, rev: TGCCAACCAGGACACCCACC
Synaptophysin fw: TTAGTTGGGGACTACTCCTCG, rev: GGCCCTTTGTTATTCTCTCGGTA
SYN1 fw: GACCAATACTGGCTCTGCGA, rev: AGGAACCCACCACCTCAATG
DRD1 fw: CTTAGGATGCTACAGACTTTGCCCTG, rev: CATGTGGGATCAGGTAAACCAGATTG
DRD2 fw: ACCAGAACGAGTGCATCATTGCC, rev: TGAAGGGCACGTAGAAGGAGACG
Primer information is related to Figures 1, 3, 4, 7. fw, forward; rev, reverse.
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bility and proved to be efficient in former studies (De Franceschi et
al., 2011a; Fo¨ller et al., 2012). The drugs were renewed with every
medium change. The stock solutions were prepared by dissolving
phallacidin in dH2O at a concentration of 1 mM and PP2 in DMSO at
a concentration of 10 mM.
Calcium imaging. Monitoring of cytosolic calcium transients was
performed as described previously (Stanslowsky et al., 2014). Cells
from ChAc patients and healthy controls were incubated for 30min at 37°C
with Fura 2-AM (Sigma-Aldrich) in standard bath solution containing the
following (in mM): 140 NaCl, 5 KCl, 2 CaCl2, 10 glucose, and 10 HEPES,
adjusted to pH 7.4 with NaOH. Intracellular Ca2 changes were imaged by
exciting Fura 2-AM at 340 and 380 nm and monitoring its emission in
intervals of 300 ms at 510 nm with the Life Acquisition Software (T.I.L.L.
Photonics) coupled to an upright microscope (Axioskop 2 FS plus; Zeiss).
Recordingswere terminatedbyapplying50mMKCl to ensure the viability of
the recorded cells. After background subtraction, the 340/380 nm excitation
ratio for Fura 2-AM was calculated, which increases as a function of the
cytosolic free Ca2 ([Ca2]i).
Figure 1. Characterization of hiPSC lines. A, All hiPSC lines used in this study expressed the pluripotencymarkers NANOG, OCT4, TRA1–81, and SSEA4 as seen by immunocytochemical stainings.
B, To showpluripotency, iPSC lineswere differentiated in vitro into cells expressingmarkers of all three germ layers: ectoderm (TUBB3), endoderm (AFP), andmesoderm (SMA). ForA andB,WT1–1
and Mut1 are shown as representative lines. Nuclei were counterstained with Hoechst. Scale bars, 100m. C, qRT-PCR revealed that all iPSC lines expressed a comparable level of pluripotency
markers as the hESC lineHUES6.D, Retroviral transgenes used for reprogrammingwere efficiently silenced in established iPSC lines. Expressionwas normalized to a freshly infected human fibroblast
sample 4 d postinfection (dpi). Data are presented as means	 SEM using GAPDH and BACT as housekeeping genes.
Figure 2. Sequential induction of hiPSCs toward MSNs. A, Schematic summary of the differentiation procedure. B–D, Phase-contrast images during in vitro differentiation. hiPSC colonies were
detached from the feeder layer and cultured in suspension as EBs in the presence of small molecules as indicated. On days 12–14, EBs were plated on Matrigel-coated cell culture dishes. Neuronal
cells started to spread out and matured through the addition of various growth factors. Scale bars, 100m.
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Reverse transcription and qRT-PCR. Total RNAwas extracted using the
RNeasy Micro Kit (Qiagen) and reversely transcribed using oligo-dT
primer and Superscript II reverse transcriptase (Life Technologies) ac-
cording tomanufacturers’ instructions. qRT-PCR experimentswere per-
formed as described previously (Stanslowsky et al., 2014). Primer
information is provided in Table 1. Target gene expressions are given as
means 	 SEM, normalized to the endogenous references (2-
microglobulin or GAPDH and ACTB) and relative to the expression in
undifferentiated iPSCs.
Statistics. Data were analyzed with GraphPad Prism 5 software if not
otherwise stated. Morphological analyses, G/F-actin ratios, and Lyn
kinase activation levels were calculated using a Student’s t test. So-
dium (INa) and potassium (IK) amplitudes during depolarization
were compared by two-way ANOVA and Bonferroni’s posttest. AP
properties, synaptic activity, calcium influx, and gene expression data
were analyzed statistically by a nonparametric Mann–Whitney test.
All data are presented as means	 SEM and the significance level was
set at p  0.05.
Results
Generation of hiPSCs from ChAc patients and
healthy controls
For functional analyses we generated human iPSCs from two
patients harboring the mutations c.4282G
C and c.7806G
A
(Mut 2) as well as confirmed absence of the chorein protein
(Mut 1 and Mut 2) by Western blots. Interestingly, the ChAc
patient cell line Mut 1 did not show an obvious mutation in
Figure 3. Differentiation of hiPSCs intoMSNs. A, TheWNT inhibitor IWP2was added either at the beginning of differentiation or at day 5 and telencephalic identity wasmonitored by analyzing
FOXG1 mRNA expression by qRT-PCR on day 5, 10, and 13. Only when IWP2 was added from day 0 the expression of the forebrain marker FOXG1 was strongly induced. Data were exemplarily
generatedwith the hiPSC lineWT1–2.B, When EBswere plated at day 8 of differentiation and fixed 2 d later, cells stained positive for the neural progenitor cell marker NESTIN and FOXG1. C, At day
21 of the differentiation process, neurons marked by the expression of TUBB3mostly expressed FOXG1. D, At day 30, different hiPSC lines of ChAc patients (Mut 1 and 2) and controls (WT 1–1 and
1–2) showed comparable expressions of the genes FOXG1,GAD67, andMAP2 as analyzed by qRT-PCR and normalized to the average expression level in undifferentiated hiPSCs.MSNswere replated
as single cells atday 30. Two days later,most of the TUBB3 neurons (E) stained also positive for FOXG1 and GABA and40%of patient and controlMSNs expressed DARPP32 (F ). The stainings
were performed in triplicate (FOXG1 and DARPP32) or duplicate (GABA). Data are shown asmeans	 SEM. ForD–F, the linesWT1–1,WT1–2,Mut1, andMut2were used.G, MatureMSNs atday
30 or older expressed TUBB3, DARPP32, MAP2, GAD67, and GABA, as shown by representative immunocytochemical staining. Scale bars, 100m.
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the VPS13A gene (encodes the 
3000 aa chorein protein),
although almost the complete exon sequence was investigated.
However, for the generation of patient-derived iPSC lines, the
loss of chorein expression wasmost important. As controls, we
derived iPSCs from three healthy age-matched females. Clonal
iPSC lines were derived from each fibroblast line. Multiple
assays were applied to confirm successful reprogramming. All
hiPSC lines expressed the pluripotency markers NANOG,
OCT4, TRA 1–81, and SSEA4 (Fig. 1A). The pluripotency was
confirmed using EB-based differentiation into cells of all three
germ layers (ectoderm, mesoderm, and endoderm) as shown
by immunochemical staining for TUBB3, AFP, and SMA (Fig.
1B). qRT-PCR demonstrated that iPSCs expressed pluripo-
tency markers at levels comparable to that of hESCs (Fig. 1C)
and showed efficient silencing of the retroviral reprogram-
ming constructs (Fig. 1D). Single nucleotide polymorphism
array-based karyotyping was used to confirm euploidy of the
generated iPSC lines (data not shown).
Figure 4. Neuronal morphology and GABAergic synaptic density of control and ChAc patient-derived cells. Control (A, C) and patient-derived (B, D) iPSCs were stained for neuronal marker
III-tubulin (red) and for GABAergic synapses (green).III-tubulin staining was combined with the ImageJ-based software NeurphologyJ to detect neuronal somata, neurites, attachment points
of neurites at the soma, and end points of neurites automatically. E, Total neurite outgrowth was quantified normalizing neurites by somata. Therefore, we divided the area of the neurites by the
area of the somata or thenumber of neurites (# neurites) by thenumber of somata (# somata). These parameters showeda tendency to be increased in patient-derived cells. In addition, total neurite
length was normalized by the number of somata, which was significantly enhanced in ChAc neurons ( p 0.05, Student’s t test). F, The number of end points of the neurites within an image was
normalized by the number of attachment points at the somagiving a quantitative expression for an increased total ramification of patient-derived cells.Moreover,we used the ImageJ-based plugin
SynapCountJ to quantify GABAergic synapses as stained in C andD. Therewas no significant difference in the synaptic density of ChAc neurons and controls. The bar graph gives the synaptic density
as synapses per 100m neurite (all bars showmeans	 SEM, n 3, where n represents a culture seeded at different dates).
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Differentiation of hiPSCs to striatal MSNs
Because particular striatal interneurons are the main target of
neurodegeneration in ChAc, we established a hiPSC differentia-
tion protocol (Fig. 2) providing a large population of GABAergic
forebrain neurons and DARPP32-immunopositive striatal
MSNs. To induce a neuroectodermal fate in hiPSCs efficiently,
we used a combination of double SMAD inhibition by dorsomor-
phin and SB-431542 and application of the porcine inhibitor
Figure 5. Altered Na currents in neurons from ChAc patients. A, Voltage-gated ion currents of neurons differentiated from iPSCs for 40 d in vitro recorded in whole-cell voltage-clamp by
depolarizing steps in increments of 10 mV from a holding potential of70 to 40 mV. Inward currents were completely blocked by TTX, identifying them as being Na driven. Outward currents
showedTEA sensitivity, indicating apotassiumdependency.B, Although themaximal INa and IK normalized to individual cell capacitances did not differ significantly in either group, sodiumchannels
in ChAcneurons activated at lower voltages and the sodiumcurrent amplitudes at30 and20mVwere significantly larger in ChAc cells. Data are presented asmeans	 SEM ( p0.05, ANOVA).
C, Expression of several sodium channel subunits tended to be upregulated in ChAc neurons as seen by qRT-PCR, which could explain the altered sodium current kinetics.
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IWP2 that prevents the production of endogenous, posterioriz-
ing WNT proteins. This strongly induced the expression of the
forebrain marker FOXG1 in the differentiating EBs (Fig. 3A).
Shortly after neural induction, the neuroepithelial cells were ven-
tralized using PMA, a small-molecule agonist of the sonic hedge-
hog signaling pathway, and plated inmaturationmedium on day
8 of differentiation. At this time point, the EBs contained neuro-
nal cells expressing the telencephalic marker FOXG1, the lateral
ganglionic eminencemarkersGSH2 andDLX2 (data not shown),
as well as the neural progenitor marker NESTIN (Fig. 3B). In the
course of maturation, the cells started to express the early neuro-
nal marker TUBB3 (Fig. 3C). Because MSNs typically have a
GABAergic phenotype, the expression of glutamate decarboxyl-
ase (GAD67), the neurotransmitter GABA, and DARPP32 was
assessed by qRT-PCR and immunocytochemical analysis. After
30 d of differentiation, the hiPSC lines analyzed showed a com-
parable expression of FOXG1, GAD67, and the mature neuronal
marker MAP2 (Fig. 3D). High-content analysis after reseeding
the cells as single cells at day 30 revealed that the different hiPSC
lines matured with a good reproducibility in respect to the
differentiation efficiency. Most of the TUBB3 neurons ex-
pressed FOXG1, 80% were GABA positive, and 40% ex-
pressed DARPP32 (Fig. 3E–G). Quantitative real-time PCR
analysis determined amore pronounced expression of dopamine
receptor 2 (DRD2) than dopamine receptor 1 (DRD1) in ChAc
and control MSNs (data not shown). Although this difference
was not significant, these data suggest that the generated mixed
MSN population in differentiated cultures is predominantly of
the D2 type (the “indirect pathway”), which is mainly affected in
neuroacanthocytosis patients (Brooks et al., 1991).
For detailedmorphological analyses ofMSN neurites, TUBB3
staining was combined with the ImageJ-based software Neur-
phologyJ to detect neuronal somata, neurites, attachment points
of neurites at the soma, and end points of neurites automatically.
Interestingly, ChAc patient-derived neurons displayed enhanced
neurite outgrowth and ramification (Fig. 4A,B,E,F). A signifi-
cant difference from controls was found for the normalized neu-
rite length/number of somata (p  0.0349, Student’s t test; Fig.
4E). To investigate synapse formation in ChAc MSNs, we quan-
tified GABA-positive synaptic boutons (Fig. 4C,D). Neurite trac-
ing with the NeuronJ plugin was applied to the SynapCountJ
plugin, detecting a similar synaptic density between patient and
control cell lines, although ChAc MSNs showed a higher degree
of ramification (Fig. 4F). The comparable number of synapses in
ChAc MSNs and controls does therefore not account for differ-
ences of synaptic activity. Furthermore, in qRT-PCR, there was
no significant difference in the mRNA expression of the synaptic
proteins SYN1 and synaptophysin between patient-derived and
control cells (data not shown).
ChAc neurons show elevated synaptic activity
Ion channel and AP properties, as well as the synaptic activity of
neurons from ChAc patient and healthy control iPSC lines, were
analyzed by whole-cell patch-clamp recordings to uncover po-
tential neuronal malfunctions. Electrophysiological measure-
ments were performed on cells with a clear neuronalmorphology
after 40 d of differentiation from a minimum of three indepen-
dent differentiation experiments. In response to depolarization,
all cells showed TEA-sensitive potassium outward currents and,
in both patient and control groups, most of the cells generated
TTX-sensitive sodium inward currents (ChAc 88.6	 4.8%, con-
trol 77.4 	 7.1%, p  0.24; Fig. 5A). The maximal INa and IK
normalized to individual cell capacitances did not differ signifi-
cantly in either group (see Table 2 for means	 SEM and sample
sizes); however, the voltage dependence of Na channel activa-
tion was shifted to more negative membrane potentials in ChAc
neurons with significantly enhanced peaks at20 and30 mV
(Fig. 5B). Using qRT-PCR, we observed a trend of upregulated
expression of several voltage-gated Na channel subunits that
may account for the altered sodium current kinetics seen inChAc
neurons (Fig. 5C).
Current-clampmode recordings revealed a comparable num-
ber of neurons from ChAc patients (58.7	 10.3%) and controls
(45.7 	 9.6%) that fired TTX-sensitive APs upon depolarizing
current injection (Fig. 6A,B). Spontaneous spiking (see Fig. 6C
for representative traces) was observed in a minor neuronal pop-
ulation (ChAc 13.9	 3.8%, control 6.7	 2.4%, p 0.12), with
no differences in frequencies when patient and control cells were
compared (Fig. 6D). Only the amplitudes of provoked and spon-
taneous APs were significantly higher in ChAc cells (p  0.004
and p 0.001; Fig. 6B,D, Table 2).
Next, we assessed the synaptic input received by the hiPSC-
derived MSNs by analyzing the spontaneous synaptic neu-
rotransmission at a holding potential of70mV. The percentage
of ChAc cells showing mPSCs was significantly elevated (ChAc
88.6 	 4.3%; control 69.5 	 5.3%, p  0.01; Fig. 7A). We ob-
served a nearly 2-fold frequency increase and significantly higher
amplitudes of mPSCs in ChAc neurons (0.57	 0.06 Hz; 11.7	
0.1 pA; n  123) compared with controls (0.30 	 0.03 Hz, p 
0.0001; 9.5	 0.4 pA, p 0.0001; n 107). The origin of mPSCs
was analyzed by extracellular application of the GABAA receptor
antagonist bicuculline and the glutamate receptor blockerNBQX
to neurons with high mPSC frequencies only. The reduction of
mPSCs by application of bicuculline suggested a predominantly
GABAergic synaptic input, which is consistent with the high
number of striatal GABAergic MSNs in our cultures. NBQX had
no significant effect on mPSCs (Fig. 7B,C).
Evaluation of the passive membrane properties in patient and
controlMSNs revealed no significant differences in restingmem-
brane potentials or input resistances. Only the cell capacitances
were significantly higher in ChAc neurons compared with con-
trols (Table 2).
Table 2. Functional properties of neurons from ChAc-iPSCs and healthy controls
Functional properties Mut (n 141) WT (n 150) p-values
Cells with Na-currents (%) 88.6	 4.8 77.4	 7.1 0.2415
Peak Na-current (pA/pF) 124.0	 8.9 104.7	 7.9 0.0930
Peak K-current (pA/pF) 126.6	 8.0 110.1	 7.3 0.0508
Na channel activation (mV)*** 28.2	 0.7 22.4	 0.8 0.0001
K channel activation (mV)*** 20.3	 0.9 15.3	 0.9 0.0001
Resting membrane potential (mV) 35.3	 0.9 32.3	 1.2 0.1568
Membrane capacitance (pF)*** 14.9	 0.6 12.5	 0.7 0.0006
Input Resistance (MOhm) 1558.0	 111.2 1389.0	 90.9 0.4835
Cells with APs (%) 58.7	 10.3 45.7	 9.6 0.3257
AP amplitude (mV)** 49.9	 1.7 42.2	 2.0 0.0041
AP duration (msec)*** 2.2	 0.1 3.1	 0.2 0.0001
AHP amplitude (mV)** 19.3	 0.7 16.5	 0.8 0.0093
Time to peak AHP (msec) 7.6	 0.2 8.1	 0.3 0.4117
Cells with spontaneous APs (%) 13.9	 3.8 6.7	 2.4 0.1220
Amplitude of spont. APs (mV)** 39.1	 0.7 34.6	 0.6 0.0012
Frequency of spont. APs (Hz) 2.4	 0.5 2.0	 0.8 0.4005
Cells with mPSCs (%)** 88.6	 4.3 69.5	 5.3 0.0087
mPSC amplitude (pA)*** 11.7	 0.1 9.5	 0.4 0.0001
mPSC frequency (Hz)*** 0.57	 0.06 0.30	 0.03 0.0001
Voltage-gated ion channel, passive membrane, and AP properties were determined by whole-cell patch-clamp
recordings. Data are given as means	 SEM. AHP, Afterhyperpolarization.
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Normal Ca2 signaling in ChAc neurons
Based on the observed elevated synaptic transmission in ChAc neu-
rons andCa2 as a trigger for the fusion of synaptic vesicles with the
plasmamembrane,we investigatedpotential alterations in the intra-
cellularCa2 signaling.ThebasicCa2 level representedby the ratio
of fluorescence emission at 340 and 380 nm from fura-2 loaded cells
was similar in ChAc cells and healthy controls. Application of the
neurotransmitters GABA, acetylcholine, glutamate, and glycine in-
duced intracellular calcium rises in comparable percentages of cells
andwith similar amplitudes in both groups (Fig. 8A–C). These data
might exclude different neurotransmitter receptor densities as a rea-
son for the variations in postsynaptic currents. GABA and glycine
induced depolarizing Ca2 signals in 20% of the cells, sug-
gesting an excitatory function of these neurotransmitters in
ChAc neurons and controls because it is typically seen in fetal
neurons (Wegner et al., 2008, 2012).
Neither the percentages of cells showing Ca2 responses
caused by application of KCl (ChAc 80.5	 9.5%; control 68.3	
8.7%, p  0.2) nor the amplitudes (ChAc 0.14 	 0.01, n  79;
control 0.18	 0.01, n 111, p 0.2) were significantly different
in either group. Spontaneous calcium influx was observed in
27.0	 6.5% of ChAc and 35.0	 10.7% of control cells (p 0.4)
with similar frequencies (ChAc 0.002	 0.0002, n 102; control
0.003	 0.0004, n 52, p 0.3) and the samemean amplitude of
0.25	 0.01 (p 0.9; Fig. 8D).
The expression of voltage-gated Ca2 channels as analyzed by
qRT-PCRwas also not significantly different between ChAc neu-
rons and healthy controls (Fig. 8E).
Figure 6. Elevated AP amplitudes in ChAc neurons. A, Differentiated cells from ChAc patients and healthy controls fired single APs in response to depolarizing current pulses in current-clamp
mode that could be blocked by 1M TTX. B, Although the percentage of cells with APs did not differ in either group, the AP amplitudes were significantly higher in ChAc neurons compared with
controls. C, Spontaneous AP firing was measured at the neuronal membrane potential over a period of 11 s. D, Spontaneous APs were observed only in a minor cell population without significant
differences in percentage or frequency, but higher amplitudes in ChAc neurons compared with controls. Data represent means	 SEM ( p 0.05, Mann–Whitney test).
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Decrease of synaptic activity in ChAc neurons to healthy
control levels by drug treatment with phallacidin and PP2
Depolymerized cortical actin has been identified in erythro-
cytes from ChAc patients (Fo¨ller et al., 2012). Because the
regulation of synaptic neurotransmitter release is actin depen-
dent (Morales et al., 2000), we hypothesized that the depo-
lymerized actin phenotype disinhibits synaptic vesicle release.
To test our hypothesis, we evaluated whether stabilization of
F-actin by incubating the cells with phallacidin might reverse
the synaptic hyperactivity seen in ChAc neurons. Indeed, the
treatment of ChAc cells with 100 nM phallacidin for 72 h
(Fo¨ller et al., 2012) reduced the frequency and amplitude of
synaptic currents to the level of healthy controls (Fig. 9A,B).
The AP amplitudes were also reduced significantly by phalla-
cidin treatment (Fig. 9C).
Another mechanistic explanation for the pathological synap-
tic currents arose from observations of increased activity of the
Src-family tyrosine kinase Lyn in erythrocytes of ChAc patients
(De Franceschi et al., 2011a). Elevated Lyn kinase activity weak-
ens the connection between the actin cytoskeleton and the cell
membrane (De Franceschi et al., 2011a) and might induce en-
hanced synaptic activity. We used the irreversible Src kinase in-
hibitor PP2 (10 M for 72 h; Williams et al., 2009; De Franceschi
et al., 2011a) to treat cells before functional analyses and found a
similar reduction of synaptic current frequency and amplitudes,
as well as AP amplitudes, compared with phallacidin treatment
(Fig. 9D–F). In both cases, the viability was not influenced, as
indicated by similar numbers of TUNEL-positive cells in treated
and untreated cultures after 40 d of differentiation (data not
shown). In contrast to this regular differentiation time, a long-
term cultivation (
3 months) of untreated ChAc MSNs and
controls revealed a significant decrease of patient-derived cells
(p  0.05, Student’s t test; Fig. 10A), suggesting a beginning
neurodegeneration.
We also investigated the voltage-gated sodium channel
blocker and AMPA glutamate receptor antagonist riluzole for its
effect on the enhanced synaptic activity in ChAc neurons. Rilu-
zole is the only Food and Drug Administration-approved drug
for the treatment of amyotrophic lateral sclerosis and has been
reported to prevent excitatory neurotransmitter release from
presynaptic nerve terminals by a reduction of cytosolic Ca2, as
well as stimulated transmitter clearance from the synapse (Azbill
et al., 2000; Dunlop et al., 2003; Wang et al., 2004). It was also
discussed as treatment for cerebellar ataxias (Romano et al.,
2015). In contrast to phallacidin and PP2, incubation with 1 M
riluzole during the whole differentiation period did not have sig-
nificant influence on the frequency or amplitudes ofmPSCs (data
not shown).
Figure 7. Enhanced spontaneous synaptic transmission in neurons derived from ChAc patient iPSCs. A, Higher percentages of ChAc neurons showed spontaneous mPSCs, which
exhibited an almost 2-fold increase in frequency and a significantly higher mean amplitude in ChAc cells compared with controls, indicating a higher synaptic activity. B, C, Application
of the AMPA receptor blocker NBQX reducedmPSC frequency just slightly, whereas the GABAA receptor blocker bicucullin decreased current frequency by 66% and 90% in ChAc and control
neurons, respectively, indicating a predominantly GABAergic synaptic input, which is consistent with the high number of GABAergic cells in our cultures. Data are presented as means	
SEM ( p 0.05, Mann–Whitney test).
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Considering our electrophysiological evidence linking F-actin
stabilization and Src kinase inhibition to enhanced activity of
ChAc MSNs, we sought to examine the actin network and dy-
namics and the activation levels of the Lyn kinase. Using qRT-
PCR, we measured the expression of -actin interacting with
chorein (Shiokawa et al., 2013) and did not find a significant
difference between patient-derived and control cells (data not
shown). Then ratios of soluble G-actin and F-actin were deter-
mined by Western blotting in differentiated patient and control
neurons of multiple clones. In contrast to midbrain dopaminer-
gic neurons (mDAN), the G/F-actin ratio of ChAc MSNs was
significantly higher than in respective controls (p  0.05, Stu-
Figure 8. ChAc neurons and controls showed similar spontaneous and neurotransmitter-induced Ca 2 signaling. A, Representative traces of transient cytosolic Ca 2 changes induced by bath
applicationofGABA (100M), acetylcholine (ACh, 100M), glutamate (Glut, 50M), glycine (Gly, 100M), andKCl (50mM) in fura-2-loadedneurons fromcontrol iPSCs. Intracellular Ca 2 changes
are presented as ratios of the fluorescence signals obtained at 340 and 380nm (F340/F380).B, Summary of cytosolic Ca
2 response amplitudes normalized to the basal Ca 2 level of the investigated
cells (n) showed no significant differences between ChAc neurons and healthy controls. C, A similar fraction of ChAc and control cells responded to neurotransmitter application obtained from
experiments as shown inA. Note: GABAandglycine induceddepolarizingCa 2 signals in20%of the cells. Therefore, theGABAergic andglycinergic synaptic transmissionpartly haveanexcitatory
function in ChAc neurons and controls. D, Analyzing spontaneous Ca 2 transients revealed no significant difference in the percentage of spontaneously active cells (30%), Ca 2 current
frequency, or amplitudes in ChAc neurons comparedwith controls. E, Genomic expression of voltage-gated calcium channel subunits analyzed by qRT-PCR did not differ significantly between ChAc
neurons and healthy controls. Data represent means	 SEM ( p 0.05, Mann–Whitney test).
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dent’s t test; Fig. 10B), suggesting a depolymerization of cortical
actin comparable to erythrocytes from ChAc patients (Fo¨ller et
al., 2012).
ROCK is a key player and signaling hub for regulation of
the actin cytoskeleton and neuronal differentiation (da Silva et
al., 2003; No¨lle et al., 2011). For the analysis of actin dysregu-
lation, we tested expression levels and phosphorylation of the
ROCK downstream targets. Nonphosphorylated cofilin has an
actin-severing activity, whereas phosphorylated profilin
blocks its own binding to G-actin (Arber et al., 1998; Shao et
al., 2008). Proteins from MSNs of two patient and control
individuals were analyzed by Western blotting (Fig. 10C).
Whereas expression levels and phosphorylation state of con-
trols did not differ, one ChAc patient-derived cell line (Mut 2)
showed a strong hyperphosphorylation of cofilin and MSNs
from another patient (Mut 1) displayed hypophosphorylation
of profilin (Fig. 10D). Although phosphorylation patterns
were not uniform, these results indicate a dysregulation of the
actin cytoskeleton in ChAc patient-derived MSNs.
Finally, we analyzed Lyn kinase activity in neurons derived
from healthy controls and ChAc patients. As shown in Figure
10, E and F, we found significantly elevated activation levels of
Lyn (phosphorylated P-Lyn396/Lyn) in MSNs (Fig. 10E) and
mDANs (Fig. 10F ) fromChAc subjects compared with healthy
controls, which is in agreement with data reported for ChAc
red cells (De Franceschi et al., 2011a). Interestingly, the MSNs
as main targets of neurodegeneration in ChAc displayed a
twofold increase of Lyn activity compared with mDAN.
Discussion
Our understanding of ChAc neuropathology at the cellular and
molecular levels is still very limited. From skin biopsies of ChAc
patients and age-matched healthy control subjects, we estab-
lished a novel iPSC-based humanmodel system to study the neu-
ropathology of the disease. In this study, we used a differentiation
protocol based on neural induction, regional patterning toward a
lateral ganglionic eminence identity, and terminal differentiation
to striatal MSNs (Aubry et al., 2008; Ma et al., 2012; Delli Carri et
al., 2013; Golas and Sander, 2016), the cell type that is mainly
affected by the neurodegenerative process, as shown by histo-
pathological analysis and magnetic resonance imaging of ChAc
patients (Hardie et al., 1991; Kutcher et al., 1999; Walterfang et
al., 2008).
Inmany neurodegenerative diseases, such as amyotrophic lat-
eral sclerosis, Parkinson’s disease, and Huntington’s disease, ex-
citotoxicity may contribute to the pathophysiological process by
which nerve cells are degenerating due to excessive synaptic
transmission (Pitt et al., 2000; Van Damme et al., 2005; Dong et
al., 2009). Using electrophysiological analysis of neurons from
ChAc-iPSCs, we observed an elevated synaptic activity thatmight
contribute to the striatal cell death seen in ChAc patients as the
disease progresses. The spontaneous postsynaptic currents that
we measured represent neurotransmitter binding events to its
receptors on the postsynaptic membrane. Because abnormal
neurotransmitter release or sodium channel expression and
function can cause seizures, skeletal muscle paralysis, and neuro-
degeneration (Waxman, 2001; Wada, 2006), symptoms that
are observed in ChAc patients, we studied ion channel and AP
properties.
Our data showed a hyperpolarizing shift in the voltage de-
pendence of Na channel activation in ChAc neurons. A shift
of the voltage dependence to the hyperpolarized direction has
also been reported in epilepsy, in which it is believed to in-
Figure 9. Treatment with the F-actin stabilizer phallacidin and the Src kinase inhibitor PP2 rescued the functional phenotype seen in ChAc neurons (n 33–98). Treatment of differentiating
cells with 100 nM phallacidin (A–C) or 10M PP2 (D–F ) 72 h before analysis decreased the frequency and amplitudes of mPSCs to the level of control cells (n 8–101). C, F, AP amplitudes were
reduced significantly by phallacidin and PP2 as well. All data are given as means	 SEM of individual cell lines and as averaged values ( p 0.05, Mann–Whitney test).
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crease the channel activity and thereby may cause hyperexci-
tation of neurons, leading to epileptic seizures that are
observed early in ChAc patients (Ogiwara et al., 2009). The
earlier activation and the higher AP amplitudes in ChAc cells
might be explained by a tendency of increased expression of
several Na channel subunits as seen by qRT-PCR (Hong et
al., 2004; Zhan et al., 2007).
As stated above, overstimulation by increased spontaneous
postsynaptic currents in ChAc neurons could result in neuro-
nal stress and even cell death via the excessive influx of water
and ions. The absence of any significant difference in ligand-
gated ion channel expression as measured by calcium-imaging
excludes differential receptor densities as a reason for the en-
hanced synaptic currents. In addition, a similar synaptic den-
sity of ChAc MSNs and controls does not contribute to the
increased synaptic activity in patient-derived cells. We hy-
pothesized that a disinhibited neurotransmitter release may
account for a potentially pathological synaptic hyperactivity
in ChAc. Neurotransmitter release at central synapses is
strongly actin dependent. Depolymerization of cortical actin
promotes exocytosis and insertion of proteins into the plasma
membrane (Morales et al., 2000; Malacombe et al., 2006). In
epithelial cells, it has been shown that endocytosis was inhib-
ited upon actin depolymerization (Gottlieb et al., 1993). A
receptor-mediated arrest of endocytosis has also been re-
ported by Lamaze et al. (1997) when actin polymeriza-
tion was blocked in the human epidermoid carcinoma cell line
A431.
Depolymerized cortical actin was found in erythrocytes
from ChAc patients (Fo¨ller et al., 2012). The observed in-
creases in the G/F-actin ratios ofMSNs and erythrocytes might
be a cell-specific phenomenon in ChAc, because mDANs have
not yet shown this pattern of actin pathology. The implica-
tions of a disturbed actin cytoskeleton on the neuronal func-
tion can be diverse ranging over dynamics of the vesicle pool
to impairment of long-term potentiation or long-term depres-
sion (Zhou et al., 2011; Lee et al., 2012). The increased G/F-
actin level and the altered phosphorylation of cofilin/profilin
in ChAc MSNs suggest a dysregulated cortical actin network.
When we treated the cells with the F-actin stabilizer phallaci-
Figure 10. Actin regulation and Lyn kinase activity in differentiated neurons. A, After at least 3 months of MSN differentiation from iPSCs, cell-culture dishes of ChAc neurons (n 5
clones, red) contained significantly fewer cells (data are given as Whiskers minimum to maximum, box 25% to 75%, median, p 0.05, Student’s t test) than healthy controls (n 4
clones, blue) when investigated with a Hoechst-based quantification assay. B, G-/F-actin ratio (soluble globular G-actin over filamentous F-actin) of MSNs (right bars) cultures
differentiated for 6 weeks is increased significantly ( p 0.05, Student’s t test) in ChAc cells (n 9 clones, red) comparedwith healthy controls (n 17 clones, blue), whereas cultivation
into mDANs (9 ChAc and 16 control clones, left bars) did not lead to marked differences. Data represent means	 SD. C, Western blots of patient and control MSNs were analyzed with
antibodies against the Rho-kinase downstream targets cofilin (left) and profilin (right). Results show different phosphorylation patterns between patient-derived and control cells. D,
Phosphorylated and nonphosphorylated levels of cofilin (black) and profilin (gray) were quantitatively measured and ratios calculated. Although expression levels and phosphorylation
state of controls did not differ, one ChAc cell line (Mut 2) showed a strong hyperphosphorylation of cofilin and cells from another patient (Mut 1) displayed hypophosphorylation of
profilin. E, Western blots with specific antibodies against active Lyn kinase (phospho-Lyn 396) and total Lyn inMSNs. The representative experiment shown is one of three separate similar
experiments, each with MSNs derived from healthy controls (Ctrl) or individual ChAc patients and each with similar results. GAPDH was used as a loading control (left). Shown is a
densitometric analysis of the immunoblots; data are shown as either a single experiment (empty circle) or as means	 SD (black circle) (n 3; *p 0.05, Student’s t test). F, Western
blot with specific antibodies against active Lyn (phospho-Lyn 396) and total Lyn in mDANs. The representative experiment shown is one of three separate similar experiments, each with
mDANs derived from healthy controls (Ctrl) or individual ChAc subjects and each with similar results. Actin was used as a loading control (left). Shown is a densitometric analysis of the
immunoblots; data are shown as either a single experiment (empty box) or as means	 SD (black circle) (n 3; *p 0.05, Student’s t test).
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din, which had reversed the abnormally enhanced G/F-actin
ratio in ChAc erythrocytes (Fo¨ller et al., 2012), the synaptic
activity in ChAc MSNs was reduced to the level of healthy
controls. These results indicate that there are cortical actin
disturbances also in MSNs from ChAc patients, leading to
synaptic hyperactivity and neuronal damage in the course of
the disease (Morales et al., 2000). After long-term differentia-
tion of 
3 months, the number of ChAc patient-derived cells
indeed showed a significant decrease compared with controls,
suggesting a beginning process of neurodegeneration.
A similar reduction of synaptic currents was observed when
the ChAc neurons were incubated with the Src kinase inhibitor
PP2. Elevated activity of the Src-family tyrosine kinase Lyn,
which leads to increased tyrosine phosphorylation of several
membrane proteins involved in anchoring the membrane to
the actin cytoskeleton, was identified in erythrocytes from
ChAc patients (De Franceschi et al., 2011a). We were able to
demonstrate significantly enhanced Lyn kinase activation lev-
els in ChAc neurons. At synapses, the synaptic vesicle release is
a tightly regulated process that requires the interaction of sev-
eral membrane proteins and cytoskeletal elements (Fon and
Edwards, 2001; Bellani et al., 2010). A weakened connection
between the actin cytoskeleton and the membrane due to ab-
normally activated Lyn kinase might therefore result in patho-
logically enhanced synaptic transmission that can be
attenuated by Src kinase inhibition.
We cannot exclude with certainty that neurons from ChAc-
iPSCsmature functionally faster than cells from healthy controls,
thus giving rise to an increased neurite outgrowth and ramifica-
tion as well as enhanced synaptic transmission. However, the
immunocytochemically detected synaptic density and the elec-
trophysiological data, such as similar percentages of cells with
sodium currents, provoked and spontaneous APs, and compara-
ble amounts of cells with calcium responses, underlined equal
differentiation and maturation abilities. Furthermore, the func-
tional phenotype rescue seen by treatment of ChAc neurons with
Src kinase inhibitor and F-actin-stabilizing compounds suggests
a pathophysiologicalmechanism rather than a simplematuration
discrepancy.
Our data indicate pathologically elevated synaptic activity in
diseased ChAc neurons that is reversed to healthy control levels
by treatment with the F-actin stabilizer phallacidin and the Src
kinase inhibitor PP2. This was underlined by significantly in-
creased G/F-actin ratios and Lyn kinase activation levels in
patient-derivedMSNs. Because Src kinases are involved in bridg-
ing themembrane to the actin cytoskeleton bymembrane protein
phosphorylation, our data suggest a cortical actin-dependent
mechanism of this dysfunctional ChAc phenotype. This study
indicates that F-actin stabilization and Src kinase inhibition rep-
resent potential treatment targets in ChAc to restore neuronal
function.
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